James J. Marino - 18 Nov 2024 Form 4 Insider Report for Celldex Therapeutics, Inc. (CLDX)

Reporting relationship: Director
Issuer ticker: CLDX
Reported as of: 18 Nov 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 20 Nov 2024, 16:02:46 UTC
Prior SEC filing: 17 Jun 2024
Next SEC filing: 09 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Sam Martin, attorney-in-fact for James J. Marino

Key filing fact

James J. Marino filed Form 4 for Celldex Therapeutics, Inc. (CLDX) on 20 Nov 2024.

Key facts

This page summarizes James J. Marino's Form 4 filing for Celldex Therapeutics, Inc. (CLDX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 20 Nov 2024, 16:02.

Change

Previous filing in this sequence was filed on 17 Jun 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLDX transaction

Common Stock

Gift

Transaction value: $0
Shares: -10,500
Change %: -83%
Price: $0.000000
Shares after: 2,204
Date: 18 Nov 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction represents a gift transfer to an immediate family member of the reporting person who does not share the same household as the reporting person.